|
1
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yiu AJ and Yiu CY: Biomarkers in
colorectal cancer. Anticancer Res. 36:1093–1102. 2016.PubMed/NCBI
|
|
4
|
Bray C, Bell LN, Liang H, Collins D and
Yale SH: Colorectal cancer screening. WMJ. 116:27–33.
2017.PubMed/NCBI
|
|
5
|
Singh H, Nugent Z, Demers AA, Kliewer EV,
Mahmud SM and Bernstein CN: The reduction in colorectal cancer
mortality after colonoscopy varies by site of the cancer.
Gastroenterology. 139:1128–1137. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brenner H, Stock C and Hoffmeister M:
Effect of screening sigmoidoscopy and screening colonoscopy on
colorectal cancer incidence and mortality: Systematic review and
meta-analysis of randomised controlled trials and observational
studies. BMJ. 348:g24672014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
US Preventive Services Task Force, ;
Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW
Jr, García FA, Gillman MW, Harper DM, Kemper AR, et al: Screening
for colorectal cancer: US Preventive Services Task Force
recommendation statement. JAMA. 315:2564–2575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bosch LJ, Carvalho B, Fijneman RJ, Jimenez
CR, Pinedo HM, van Engeland M and Meijer GA: Molecular tests for
colorectal cancer screening. Clin Colorectal Cancer. 10:8–23. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grützmann R, Molnar B, Pilarsky C,
Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F,
Roblick UJ, et al: Sensitive detection of colorectal cancer in
peripheral blood by septin 9 DNA methylation assay. PLoS One.
3:e37592008. View Article : Google Scholar
|
|
10
|
Church TR, Wandell M, Lofton-Day C, Mongin
SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T,
Osborn N, et al: Prospective evaluation of methylated SEPT9 in
plasma for detection of asymptomatic colorectal cancer. Gut.
63:317–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imperiale TF, Ransohoff DF, Itzkowitz SH,
Levin TR, Lavin P, Lidgard GP, Ahlquist DA and Berger BM:
Multitarget stool DNA testing for colorectal-cancer screening. N
Engl J Med. 370:1287–1297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Redwood DG, Asay ED, Blake ID, Sacco PE,
Christensen CM, Sacco FD, Tiesinga JJ, Devens ME, Alberts SR,
Mahoney DW, et al: Stool DNA testing for screening detection of
colorectal neoplasia in Alaska native people. Mayo Clin Proc.
91:61–70. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang P and He X: Current research on
circular RNAs associated with colorectal cancer. Scand J
Gastroenterol. 52:1203–1210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei B, Tian Z, Fan W and Ni B: Circular
RNA: A novel biomarker and therapeutic target for human cancers.
Int J Med Sci. 16:292–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ng WL, Mohd Mohidin TB and Shukla K:
Functional role of circular RNAs in cancer development and
progression. RNA Biol. 15:995–1005. 2018.PubMed/NCBI
|
|
16
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ashwal-Fluss R, Meyer M, Pamudurti NR,
Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and
Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol
Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Du WW, Fang L, Yang W, Wu N, Awan FM, Yang
Z and Yang BB: Induction of tumor apoptosis through a circular RNA
enhancing Foxo3 activity. Cell Death Differ. 24:357–370. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Zhang XO, Chen T, Xiang JF, Yin
QF, Xing YH, Zhu S, Yang L and Chen LL: Circular intronic long
noncoding RNAs. Mol Cell. 51:792–806. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bustin SA: The reproducibility of
biomedical research: Sleepers awake! Biomol Detect Quantif.
2:35–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Contopoulos-Ioannidis DG, Ntzani E and
Ioannidis JP: Translation of highly promising basic science
research into clinical applications. Am J Med. 11:477–484. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ioannidis JP: Evolution and translation of
research findings: From bench to where? PLoS Clin Trials.
1:e362006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prinz F, Schlange T and Asadullah K:
Believe it or not: How much can we rely on published data on
potential drug targets? Nat Rev Drug Discov. 10:7122011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Begley CG and Ellis LM: Drug development:
Raise standards for preclinical cancer research. Nature.
483:531–533. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bustin S and Nolan T: Talking the talk,
but not walking the walk: RT-qPCR as a paradigm for the lack of
reproducibility in molecular research. Eur J Clin Invest.
47:756–774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weng W, Wei Q, Toden S, Yoshida K,
Nagasaka T, Fujiwara T, Cai S, Qin H, Ma Y and Goel A: Circular RNA
ciRS-7-A promising prognostic biomarker and a potential therapeutic
target in colorectal cancer. Clin Cancer Res. 23:3918–3928. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barbagallo C, Brex D, Caponnetto A,
Cirnigliaro M, Scalia M, Magnano A, Caltabiano R, Barbagallo D,
Biondi A, Cappellani A, et al: LncRNA UCA1, upregulated in CRC
biopsies and downregulated in serum exosomes, controls mRNA
expression by RNA-RNA interactions. Mol Ther Nucleic Acids.
7:229–241. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang W, Ji M, He G, Yang L, Niu Z, Jian M,
Wei Y, Ren L and Xu J: Silencing CDR1as inhibits colorectal cancer
progression through regulating microRNA-7. Onco Targets Ther.
10:2045–2056. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bachmayr-Heyda A, Reiner AT, Auer K,
Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW,
Zeillinger R and Pils D: Correlation of circular RNA abundance with
proliferation-exemplified with colorectal and ovarian cancer,
idiopathic lung fibrosis, and normal human tissues. Sci Rep.
5:80572015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin Y, Yu LL, Zhang B, Liu CF and Chen Y:
Circular RNA hsa_circ_0000523 regulates the proliferation and
apoptosis of colorectal cancer cells as miRNA sponge. Braz J Med
Biol Res. 51:e78112018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li F, Huang Q, Gong Z, Wang H and Chen J:
Diagnostic and prognostic roles of circ-SHPRH for solid cancers: A
meta-analysis. Onco Targets Ther. 12:4351–4357. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji W, Qiu C, Wang M, Mao N, Wu S and Dai
Y: Hsa_circ_0001649: A circular RNA and potential novel biomarker
for colorectal cancer. Biochem Biophys Res Commun. 497:122–126.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruan H, Deng X, Dong L, Yang D, Xu Y, Peng
H and Guan M: Circular RNA circ_0002138 is down-regulated and
suppresses cell proliferation in colorectal cancer. Biomed
Pharmacother. 111:1022–1028. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T,
Sun H, Pan Y, He B and Wang S: CircHIPK3 promotes colorectal cancer
growth and metastasis by sponging miR-7. Cell Death Dis. 9:4172018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li XN, Wang ZJ, Ye CX, Zhao BC, Li ZL and
Yang Y: RNA sequencing reveals the expression profiles of circRNA
and indicates that circDDX17 acts as a tumor suppressor in
colorectal cancer. J Exp Clin Cancer Res. 37:3252018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li XN, Wang ZJ, Ye CX, Zhao BC, Huang XX
and Yang L: Circular RNA circVAPA is up-regulated and exerts
oncogenic properties by sponging miR-101 in colorectal cancer.
Biomed Pharmacother. 112:1086112019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen S, Zhang L, Su Y and Zhang X:
Screening potential biomarkers for colorectal cancer based on
circular RNA chips. Oncol Rep. 39:2499–2512. 2018.PubMed/NCBI
|
|
39
|
Yuan Y, Liu W, Zhang Y, Zhang Y and Sun S:
CircRNA circ_0026344 as a prognostic biomarker suppresses
colorectal cancer progression via microRNA-21 and microRNA-31.
Biochem Biophys Res Commun. 503:870–875. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Z, Song N, Wang Y, Zhong J, Gu T,
Yang L, Shen X, Li Y, Yang X, Liu X, et al: Analysis of
differentially expressed circular RNAs for the identification of a
coexpression RNA network and signature in colorectal cancer. J Cell
Biochem. 120:6409–6419. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu H, Wang C, Song H, Xu Y and Ji G:
RNA-Seq profiling of circular RNAs in human colorectal cancer liver
metastasis and the potential biomarkers. Mol Cancer. 18:82019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang L, Peng X, Lu X, Wei Q, Chen M and
Liu L: Inhibition of hsa_circ_0001313 (circCCDC66) induction
enhances the radio-sensitivity of colon cancer cells via tumor
suppressor miR-338-3p: Effects of cicr_0001313 on colon cancer
radio-sensitivity. Pathol Res Pract. 215:689–696. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hsiao KY, Lin YC, Gupta SK, Chang N, Yen
L, Sun HS and Tsai SJ: Noncoding effects of circular RNA CCDC66
promote colon cancer growth and metastasis. Cancer Res.
77:2339–2350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang XL, Xu LL and Wang F:
Hsa_circ_0020397 regulates colorectal cancer cell viability,
apoptosis and invasion by promoting the expression of the miR-138
targets TERT and PD-L1. Cell Biol Int. 41:1056–1064. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang R, Xu J, Zhao J and Wang X:
Silencing of hsa_circ_0007534 suppresses proliferation and induces
apoptosis in colorectal cancer cells. Eur Rev Med Pharmacol Sci.
22:118–126. 2018.PubMed/NCBI
|
|
46
|
Li X, Wang J, Zhang C, Lin C, Zhang J,
Zhang W, Zhang W, Lu Y, Zheng L and Li X: Circular RNA circITGA7
inhibits colorectal cancer growth and metastasis by modulating the
Ras pathway and upregulating transcription of its host gene ITGA7.
J Pathol. 246:166–179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Z, Su M, Xiang B, Zhao K and Qin B:
Circular RNA PVT1 promotes metastasis via miR-145 sponging in CRC.
Biochem Biophys Res Commun. 512:716–722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z,
Xu B, Wu C, Zhou Q, Hu W, Wu C and Jiang J: A novel protein encoded
by a circular RNA circPPP1R12A promotes tumor pathogenesis and
metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer.
18:472019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bian L, Zhi X, Ma L, Zhang J, Chen P, Sun
S, Li J, Sun Y and Qin J: Hsa_circRNA_103809 regulated the cell
proliferation and migration in colorectal cancer via
miR-532-3p/FOXO4 axis. Biochem Biophys Res Commun. 505:346–352.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang P, Zuo Z, Shang W, Wu A, Bi R, Wu J,
Li S, Sun X and Jiang L: Identification of differentially expressed
circular RNAs in human colorectal cancer. Tumour Biol.
39:10104283176945462017.PubMed/NCBI
|
|
51
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 4:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
ThermoFisher Scientific: qPCR efficiency
calculator. https://www.thermofisher.com/uk/en/home/brands/thermo-scientific/molecular-biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientific-web-tools/qpcr-efficiency-calculator.htmlDecember
23–2020PubMed/NCBI
|
|
53
|
Goksuluk D, Korkmaz S, Zararsiz G and
Karaağaoğlu AE: easyROC: An interactive web-tool for ROC curve
analysis using R language environment. Contributed Res. 8:213–230.
2016.
|
|
54
|
Zhu Y, Yang C, Weng M, Zhang Y, Yang C,
Jin Y, Yang W, He Y, Wu Y, Zhang Y, et al: Identification of
TMEM208 and PQLC2 as reference genes for normalizing mRNA
expression in colorectal cancer treated with aspirin. Oncotarget.
8:22759–22771. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Guo C, Liu S and Sun MZ: Novel insight
into the role of GAPDH playing in tumor. Clin Transl Oncol.
15:167–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Das S, Chandrasekaran AP, Suresh B, Haq S,
Kang JH, Lee SJ, Kim J, Kim J, Lee S, Kim HH, et al: Genome-scale
screening of deubiquitinase subfamily identifies USP3 as a
stabilizer of Cdc25A regulating cell cycle in cancer. Cell Death
Differ. 27:3004–3020. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li Y, Ge YZ, Xu L, Xu Z, Dou Q and Jia R:
The potential roles of RNA N6-methyladenosine in urological tumors.
Front Cell Dev Biol. 8:5799192020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang H, Xu B and Shi J: N6-methyladenosine
METTL3 promotes the breast cancer progression via targeting Bcl-2.
Gene. 722:1440762020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang Q, Geng W, Guo H, Wang Z, Xu K, Chen
C and Wang S: Emerging role of RNA methyltransferase METTL3 in
gastrointestinal cancer. J Hematol Oncol. 13:572020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zeng C, Huang W, Li Y and Weng H: Roles of
METTL3 in cancer: Mechanisms and therapeutic targeting. J Hematol
Oncol. 13:1172020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fan L, Chen Z, Wu X, Cai X, Feng S, Lu J,
Wang H and Liu N: Ubiquitin-specific protease 3 promotes
glioblastoma cell invasion and epithelial-mesenchymal transition
via stabilizing snail. Mol Cancer Res. 10:1975–1984. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Fang CL, Lin CC, Chen HK, Hseu YC, Hung
ST, Sun DP, Uen YH and Lin KY: Ubiquitin-specific protease 3
overexpression promotes gastric carcinogenesis and is predictive of
poor patient prognosis. Cancer Sci. 109:3438–3449. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liao XH, Wang Y, Zhong B and Zhu SY: USP3
promotes proliferation of non-small cell lung cancer through
regulating RBM4. Eur Rev Med Pharmacol Sci. 6:3143–3151.
2020.PubMed/NCBI
|
